

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 5.24094353 |
| 2 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.08089856 |
| 3 | regulation of synapse structural plasticity (GO:0051823) | 5.02799416 |
| 4 | locomotory exploration behavior (GO:0035641) | 4.93781180 |
| 5 | response to peptidoglycan (GO:0032494) | 4.86396701 |
| 6 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.80094702 |
| 7 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.73552125 |
| 8 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.52794288 |
| 9 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.46236123 |
| 10 | synaptic vesicle maturation (GO:0016188) | 4.43290447 |
| 11 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.43092064 |
| 12 | negative regulation of interleukin-12 production (GO:0032695) | 4.41004493 |
| 13 | detection of molecule of bacterial origin (GO:0032490) | 4.39076661 |
| 14 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.35048926 |
| 15 | macrophage activation involved in immune response (GO:0002281) | 4.27305484 |
| 16 | synaptic vesicle exocytosis (GO:0016079) | 4.27118046 |
| 17 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.21860764 |
| 18 | immunoglobulin mediated immune response (GO:0016064) | 4.21793913 |
| 19 | positive regulation by symbiont of host defense response (GO:0052509) | 4.12756892 |
| 20 | modulation by symbiont of host defense response (GO:0052031) | 4.12756892 |
| 21 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.12756892 |
| 22 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.12756892 |
| 23 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.12756892 |
| 24 | modulation by symbiont of host immune response (GO:0052553) | 4.12756892 |
| 25 | vocalization behavior (GO:0071625) | 4.04133263 |
| 26 | prepulse inhibition (GO:0060134) | 4.03000858 |
| 27 | microglial cell activation (GO:0001774) | 4.01932695 |
| 28 | positive regulation of mast cell activation (GO:0033005) | 3.99215856 |
| 29 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.94694059 |
| 30 | synaptic transmission, glutamatergic (GO:0035249) | 3.83020343 |
| 31 | cellular extravasation (GO:0045123) | 3.81541709 |
| 32 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.78808548 |
| 33 | neuron-neuron synaptic transmission (GO:0007270) | 3.78614799 |
| 34 | synaptic transmission, dopaminergic (GO:0001963) | 3.77705933 |
| 35 | macrophage activation (GO:0042116) | 3.75615455 |
| 36 | neuronal action potential propagation (GO:0019227) | 3.74131843 |
| 37 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.73116481 |
| 38 | exploration behavior (GO:0035640) | 3.72516901 |
| 39 | glutamate receptor signaling pathway (GO:0007215) | 3.72450161 |
| 40 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.70177987 |
| 41 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.69714883 |
| 42 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.66695581 |
| 43 | positive regulation of mast cell degranulation (GO:0043306) | 3.66408741 |
| 44 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.66408741 |
| 45 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.63203462 |
| 46 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.63019289 |
| 47 | protein localization to synapse (GO:0035418) | 3.62534245 |
| 48 | regulation of synaptic vesicle transport (GO:1902803) | 3.61795109 |
| 49 | neutrophil activation (GO:0042119) | 3.58324729 |
| 50 | mast cell activation involved in immune response (GO:0002279) | 3.56786326 |
| 51 | mast cell degranulation (GO:0043303) | 3.56786326 |
| 52 | positive regulation of membrane potential (GO:0045838) | 3.55814784 |
| 53 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.54429360 |
| 54 | detection of other organism (GO:0098543) | 3.53953508 |
| 55 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.53914604 |
| 56 | detection of external biotic stimulus (GO:0098581) | 3.49444289 |
| 57 | granulocyte activation (GO:0036230) | 3.49159280 |
| 58 | long-term memory (GO:0007616) | 3.48040100 |
| 59 | neurotransmitter secretion (GO:0007269) | 3.47791472 |
| 60 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.47275711 |
| 61 | regulation of mast cell activation (GO:0033003) | 3.47208208 |
| 62 | B cell mediated immunity (GO:0019724) | 3.43302021 |
| 63 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.41223707 |
| 64 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.40113847 |
| 65 | regulation of postsynaptic membrane potential (GO:0060078) | 3.39621135 |
| 66 | response to histamine (GO:0034776) | 3.37288116 |
| 67 | response to amphetamine (GO:0001975) | 3.36946254 |
| 68 | synaptic vesicle endocytosis (GO:0048488) | 3.35835188 |
| 69 | T-helper 1 type immune response (GO:0042088) | 3.35453677 |
| 70 | striatum development (GO:0021756) | 3.34278720 |
| 71 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.33385072 |
| 72 | cellular response to ethanol (GO:0071361) | 3.33058483 |
| 73 | regulation of mast cell degranulation (GO:0043304) | 3.32668205 |
| 74 | adenosine receptor signaling pathway (GO:0001973) | 3.30298676 |
| 75 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.29901537 |
| 76 | gamma-aminobutyric acid transport (GO:0015812) | 3.28043156 |
| 77 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.26571189 |
| 78 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.26194878 |
| 79 | positive regulation of neurotransmitter transport (GO:0051590) | 3.24528944 |
| 80 | proline transport (GO:0015824) | 3.23790307 |
| 81 | glutamate secretion (GO:0014047) | 3.23275781 |
| 82 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.23106499 |
| 83 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.23090532 |
| 84 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.22724275 |
| 85 | mast cell activation (GO:0045576) | 3.22098560 |
| 86 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.20624818 |
| 87 | response to host immune response (GO:0052572) | 3.20624818 |
| 88 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.19858851 |
| 89 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.18691622 |
| 90 | germinal center formation (GO:0002467) | 3.15610364 |
| 91 | negative regulation of interleukin-17 production (GO:0032700) | 3.15076770 |
| 92 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.12696023 |
| 93 | neuromuscular process controlling balance (GO:0050885) | 3.10857910 |
| 94 | regulation of synaptic plasticity (GO:0048167) | 3.09522925 |
| 95 | neutrophil mediated immunity (GO:0002446) | 3.08182574 |
| 96 | regulation of interferon-alpha production (GO:0032647) | 3.08148920 |
| 97 | detection of biotic stimulus (GO:0009595) | 3.07555721 |
| 98 | auditory behavior (GO:0031223) | 3.06340116 |
| 99 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.04385382 |
| 100 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.02852720 |
| 101 | negative regulation of dendrite development (GO:2000171) | 3.02739410 |
| 102 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.01276827 |
| 103 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.01208131 |
| 104 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.00884695 |
| 105 | defense response to protozoan (GO:0042832) | 3.00793732 |
| 106 | positive regulation of type 2 immune response (GO:0002830) | 3.00654331 |
| 107 | detection of bacterium (GO:0016045) | 2.99179738 |
| 108 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.98509690 |
| 109 | long-term synaptic potentiation (GO:0060291) | 2.97558089 |
| 110 | mature B cell differentiation involved in immune response (GO:0002313) | 2.97548953 |
| 111 | dopamine receptor signaling pathway (GO:0007212) | 2.97520665 |
| 112 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.96873427 |
| 113 | response to auditory stimulus (GO:0010996) | 2.96707707 |
| 114 | cAMP catabolic process (GO:0006198) | 2.96148257 |
| 115 | neuron cell-cell adhesion (GO:0007158) | 2.95625164 |
| 116 | behavioral response to cocaine (GO:0048148) | 2.93377840 |
| 117 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.92380017 |
| 118 | positive regulation of interferon-alpha production (GO:0032727) | 2.92295031 |
| 119 | B cell receptor signaling pathway (GO:0050853) | 2.92291757 |
| 120 | visual learning (GO:0008542) | 2.91810916 |
| 121 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.91501020 |
| 122 | activation of protein kinase A activity (GO:0034199) | 2.90423636 |
| 123 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.89610577 |
| 124 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.89467849 |
| 125 | response to muramyl dipeptide (GO:0032495) | 2.89158283 |
| 126 | membrane depolarization (GO:0051899) | 2.88930720 |
| 127 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.88674861 |
| 128 | regulation of interleukin-17 production (GO:0032660) | 2.88189272 |
| 129 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.87902640 |
| 130 | positive regulation of leukocyte degranulation (GO:0043302) | 2.87365192 |
| 131 | behavioral defense response (GO:0002209) | 2.86720990 |
| 132 | behavioral fear response (GO:0001662) | 2.86720990 |
| 133 | regulation of glutamate secretion (GO:0014048) | 2.86607522 |
| 134 | regulation of platelet activation (GO:0010543) | 2.86194730 |
| 135 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.85504262 |
| 136 | response to host (GO:0075136) | 2.85504262 |
| 137 | response to host defenses (GO:0052200) | 2.85504262 |
| 138 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.84509633 |
| 139 | myeloid leukocyte activation (GO:0002274) | 2.84411885 |
| 140 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.83540983 |
| 141 | regulation of leukocyte degranulation (GO:0043300) | 2.82932992 |
| 142 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.81915917 |
| 143 | response to protozoan (GO:0001562) | 2.80864389 |
| 144 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.80798326 |
| 145 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.80798326 |
| 146 | regulation of neurotransmitter levels (GO:0001505) | 2.80304748 |
| 147 | transmission of nerve impulse (GO:0019226) | 2.80257869 |
| 148 | mechanosensory behavior (GO:0007638) | 2.78650810 |
| 149 | regulation of neurotransmitter secretion (GO:0046928) | 2.78609559 |
| 150 | regulation of protein kinase A signaling (GO:0010738) | 2.78113949 |
| 151 | regulation of neurotransmitter transport (GO:0051588) | 2.77236077 |
| 152 | superoxide anion generation (GO:0042554) | 2.75734768 |
| 153 | positive regulation of interleukin-6 production (GO:0032755) | 2.75042371 |
| 154 | neurotransmitter transport (GO:0006836) | 2.74877630 |
| 155 | positive regulation of macrophage cytokine production (GO:0060907) | 2.74576072 |
| 156 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.74212744 |
| 157 | learning (GO:0007612) | 2.73520824 |
| 158 | regulation of macrophage cytokine production (GO:0010935) | 2.73359297 |
| 159 | endothelium development (GO:0003158) | 2.73274976 |
| 160 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.71981414 |
| 161 | regulation of gamma-delta T cell activation (GO:0046643) | 2.71923301 |
| 162 | myeloid leukocyte mediated immunity (GO:0002444) | 2.71728605 |
| 163 | neutrophil chemotaxis (GO:0030593) | 2.71305611 |
| 164 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.71148155 |
| 165 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.71148155 |
| 166 | positive regulation of B cell differentiation (GO:0045579) | 2.70604170 |
| 167 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.69831149 |
| 168 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.69706813 |
| 169 | negative regulation of cell killing (GO:0031342) | 2.69503463 |
| 170 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.69503463 |
| 171 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.69426588 |
| 172 | regulation of tolerance induction (GO:0002643) | 2.68799384 |
| 173 | histamine secretion (GO:0001821) | 2.67579933 |
| 174 | regulation of antigen processing and presentation (GO:0002577) | 2.67417311 |
| 175 | postsynaptic membrane organization (GO:0001941) | 2.67336549 |
| 176 | visual behavior (GO:0007632) | 2.67266656 |
| 177 | cellular potassium ion homeostasis (GO:0030007) | 2.67053934 |
| 178 | regulation of dendritic spine development (GO:0060998) | 2.66759885 |
| 179 | membrane depolarization during action potential (GO:0086010) | 2.64845247 |
| 180 | neutrophil migration (GO:1990266) | 2.63784449 |
| 181 | regulation of vesicle fusion (GO:0031338) | 2.63738029 |
| 182 | myeloid cell activation involved in immune response (GO:0002275) | 2.63198483 |
| 183 | negative regulation of amino acid transport (GO:0051956) | 2.62950107 |
| 184 | positive regulation of interleukin-10 production (GO:0032733) | 2.62872175 |
| 185 | positive regulation of synaptic transmission (GO:0050806) | 2.62310369 |
| 186 | fear response (GO:0042596) | 2.61935459 |
| 187 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.61211558 |
| 188 | T cell migration (GO:0072678) | 2.60257810 |
| 189 | leukocyte degranulation (GO:0043299) | 2.59844027 |
| 190 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.57512674 |
| 191 | positive regulation of interferon-beta production (GO:0032728) | 2.57147690 |
| 192 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.56927335 |
| 193 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.56702641 |
| 194 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.56185256 |
| 195 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.56008180 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.62434542 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.61154195 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.54849928 |
| 4 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.94416315 |
| 5 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.70628495 |
| 6 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.62900159 |
| 7 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.58066623 |
| 8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.51676653 |
| 9 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.51298862 |
| 10 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.46084018 |
| 11 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.40963534 |
| 12 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.40794203 |
| 13 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.30276902 |
| 14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.29905801 |
| 15 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.28057007 |
| 16 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.24237782 |
| 17 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.11035320 |
| 18 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.07528901 |
| 19 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.03640846 |
| 20 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.01920654 |
| 21 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.99297683 |
| 22 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.99074560 |
| 23 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.97634621 |
| 24 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.97389260 |
| 25 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.97282580 |
| 26 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.95573069 |
| 27 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.94242755 |
| 28 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.94242755 |
| 29 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.93310131 |
| 30 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.91660212 |
| 31 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.88629139 |
| 32 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.85647727 |
| 33 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.80301832 |
| 34 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.79905198 |
| 35 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.79615012 |
| 36 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.77897006 |
| 37 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.74847838 |
| 38 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.74839549 |
| 39 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.73549945 |
| 40 | MYB_26560356_Chip-Seq_TH2_Human | 1.69505518 |
| 41 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.66676131 |
| 42 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.65022626 |
| 43 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.63720163 |
| 44 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.62777965 |
| 45 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.61158391 |
| 46 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.60313056 |
| 47 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.59779299 |
| 48 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.58258513 |
| 49 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.58187641 |
| 50 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.57895395 |
| 51 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.56067544 |
| 52 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55317872 |
| 53 | SPI1_23127762_ChIP-Seq_K562_Human | 1.55141316 |
| 54 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.52566392 |
| 55 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.51732953 |
| 56 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.50990715 |
| 57 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.48065859 |
| 58 | P300_19829295_ChIP-Seq_ESCs_Human | 1.44640326 |
| 59 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.43654023 |
| 60 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.40908720 |
| 61 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.40037430 |
| 62 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.38577793 |
| 63 | GATA3_26560356_Chip-Seq_TH2_Human | 1.38396320 |
| 64 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.35979140 |
| 65 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.35412255 |
| 66 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33497597 |
| 67 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.31786927 |
| 68 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.30834568 |
| 69 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.30277698 |
| 70 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.29809903 |
| 71 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.29539371 |
| 72 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.28267311 |
| 73 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.27980017 |
| 74 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.27621742 |
| 75 | GATA1_19941826_ChIP-Seq_K562_Human | 1.26880758 |
| 76 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.24678784 |
| 77 | MYB_26560356_Chip-Seq_TH1_Human | 1.24112430 |
| 78 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.21667663 |
| 79 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.21667663 |
| 80 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.19022153 |
| 81 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.18375782 |
| 82 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.18151031 |
| 83 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.18116059 |
| 84 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.16004673 |
| 85 | TP53_16413492_ChIP-PET_HCT116_Human | 1.14623508 |
| 86 | GATA2_19941826_ChIP-Seq_K562_Human | 1.13244772 |
| 87 | GATA1_22025678_ChIP-Seq_K562_Human | 1.12266706 |
| 88 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.12127668 |
| 89 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.12114509 |
| 90 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.10942597 |
| 91 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.10443075 |
| 92 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.09035465 |
| 93 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.08823624 |
| 94 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.08761717 |
| 95 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.08692989 |
| 96 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.08678811 |
| 97 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.07342572 |
| 98 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.07031200 |
| 99 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.06334746 |
| 100 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.05882005 |
| 101 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.05500130 |
| 102 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.05366394 |
| 103 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.04293185 |
| 104 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.03985888 |
| 105 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.03946881 |
| 106 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.03218474 |
| 107 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.02734354 |
| 108 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.02701611 |
| 109 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01430623 |
| 110 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.01121183 |
| 111 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.00290839 |
| 112 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.99834312 |
| 113 | RXR_22108803_ChIP-Seq_LS180_Human | 0.99217560 |
| 114 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.98208727 |
| 115 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.98033016 |
| 116 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.97948443 |
| 117 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.95609381 |
| 118 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95560949 |
| 119 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.94413556 |
| 120 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.93791230 |
| 121 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.93206942 |
| 122 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.92526123 |
| 123 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.91164384 |
| 124 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.90751844 |
| 125 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.90375227 |
| 126 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.89933045 |
| 127 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.89775292 |
| 128 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.89432728 |
| 129 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.89046665 |
| 130 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.89038062 |
| 131 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.88426215 |
| 132 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.88386754 |
| 133 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.87968732 |
| 134 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.87932321 |
| 135 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.87477138 |
| 136 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.87231549 |
| 137 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86858440 |
| 138 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.86402299 |
| 139 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.85868421 |
| 140 | MAF_26560356_Chip-Seq_TH1_Human | 0.85706159 |
| 141 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.85560029 |
| 142 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.85257337 |
| 143 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.85164909 |
| 144 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.84398533 |
| 145 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.84099421 |
| 146 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.83965741 |
| 147 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.83921469 |
| 148 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.81775649 |
| 149 | CJUN_26792858_Chip-Seq_BT549_Human | 0.80208585 |
| 150 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.79024573 |
| 151 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.78970772 |
| 152 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.77703452 |
| 153 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.77471516 |
| 154 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.75223487 |
| 155 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.74525132 |
| 156 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.74322827 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.72913619 |
| 2 | MP0002822_catalepsy | 4.31311893 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.61003447 |
| 4 | MP0003880_abnormal_central_pattern | 3.54172052 |
| 5 | MP0009745_abnormal_behavioral_response | 3.26935894 |
| 6 | MP0009046_muscle_twitch | 2.99074613 |
| 7 | MP0002063_abnormal_learning/memory/cond | 2.94470208 |
| 8 | MP0001968_abnormal_touch/_nociception | 2.85423292 |
| 9 | MP0002064_seizures | 2.73690153 |
| 10 | MP0000569_abnormal_digit_pigmentation | 2.67354024 |
| 11 | MP0006082_CNS_inflammation | 2.52786238 |
| 12 | MP0002572_abnormal_emotion/affect_behav | 2.47805261 |
| 13 | MP0004270_analgesia | 2.40524983 |
| 14 | MP0003828_pulmonary_edema | 2.26100398 |
| 15 | MP0002736_abnormal_nociception_after | 2.25661120 |
| 16 | MP0009764_decreased_sensitivity_to | 2.20374813 |
| 17 | MP0002272_abnormal_nervous_system | 2.16990422 |
| 18 | MP0001486_abnormal_startle_reflex | 2.13397619 |
| 19 | MP0000465_gastrointestinal_hemorrhage | 2.11096160 |
| 20 | MP0001501_abnormal_sleep_pattern | 2.10799489 |
| 21 | MP0005423_abnormal_somatic_nervous | 2.05621456 |
| 22 | MP0008569_lethality_at_weaning | 2.02377268 |
| 23 | MP0002735_abnormal_chemical_nociception | 2.02137726 |
| 24 | MP0001188_hyperpigmentation | 1.95008948 |
| 25 | MP0005451_abnormal_body_composition | 1.94034001 |
| 26 | MP0008004_abnormal_stomach_pH | 1.92303883 |
| 27 | MP0003075_altered_response_to | 1.89251194 |
| 28 | MP0002734_abnormal_mechanical_nocicepti | 1.86387561 |
| 29 | MP0000343_altered_response_to | 1.83253051 |
| 30 | MP0005646_abnormal_pituitary_gland | 1.81835244 |
| 31 | MP0003300_gastrointestinal_ulcer | 1.80075562 |
| 32 | MP0005174_abnormal_tail_pigmentation | 1.79572986 |
| 33 | MP0003172_abnormal_lysosome_physiology | 1.77304881 |
| 34 | MP0001835_abnormal_antigen_presentation | 1.76164768 |
| 35 | MP0001970_abnormal_pain_threshold | 1.75352670 |
| 36 | MP0002733_abnormal_thermal_nociception | 1.74358714 |
| 37 | MP0005464_abnormal_platelet_physiology | 1.67479043 |
| 38 | MP0003191_abnormal_cellular_cholesterol | 1.66513330 |
| 39 | MP0003879_abnormal_hair_cell | 1.65634373 |
| 40 | MP0005386_behavior/neurological_phenoty | 1.65185242 |
| 41 | MP0004924_abnormal_behavior | 1.65185242 |
| 42 | MP0002067_abnormal_sensory_capabilities | 1.63151970 |
| 43 | MP0005409_darkened_coat_color | 1.63094571 |
| 44 | MP0001533_abnormal_skeleton_physiology | 1.62774358 |
| 45 | MP0003656_abnormal_erythrocyte_physiolo | 1.60279457 |
| 46 | MP0004510_myositis | 1.60236426 |
| 47 | MP0003183_abnormal_peptide_metabolism | 1.60160189 |
| 48 | MP0005167_abnormal_blood-brain_barrier | 1.58093447 |
| 49 | MP0002405_respiratory_system_inflammati | 1.56931448 |
| 50 | MP0001529_abnormal_vocalization | 1.55994283 |
| 51 | MP0004147_increased_porphyrin_level | 1.54079627 |
| 52 | MP0001845_abnormal_inflammatory_respons | 1.52359091 |
| 53 | MP0009278_abnormal_bone_marrow | 1.51713883 |
| 54 | MP0003303_peritoneal_inflammation | 1.51630008 |
| 55 | MP0010155_abnormal_intestine_physiology | 1.49380110 |
| 56 | MP0001440_abnormal_grooming_behavior | 1.48768128 |
| 57 | MP0009785_altered_susceptibility_to | 1.47444580 |
| 58 | MP0004811_abnormal_neuron_physiology | 1.47441848 |
| 59 | MP0005083_abnormal_biliary_tract | 1.47269333 |
| 60 | MP0006054_spinal_hemorrhage | 1.47169422 |
| 61 | MP0001853_heart_inflammation | 1.46989431 |
| 62 | MP0002909_abnormal_adrenal_gland | 1.44955390 |
| 63 | MP0003633_abnormal_nervous_system | 1.43429854 |
| 64 | MP0008874_decreased_physiological_sensi | 1.42576164 |
| 65 | MP0004947_skin_inflammation | 1.42503154 |
| 66 | MP0000015_abnormal_ear_pigmentation | 1.40972503 |
| 67 | MP0002419_abnormal_innate_immunity | 1.40032288 |
| 68 | MP0002332_abnormal_exercise_endurance | 1.38439348 |
| 69 | MP0001986_abnormal_taste_sensitivity | 1.36399460 |
| 70 | MP0001905_abnormal_dopamine_level | 1.35780965 |
| 71 | MP0002557_abnormal_social/conspecific_i | 1.28687163 |
| 72 | MP0002998_abnormal_bone_remodeling | 1.27443171 |
| 73 | MP0008469_abnormal_protein_level | 1.27356722 |
| 74 | MP0003436_decreased_susceptibility_to | 1.26121537 |
| 75 | MP0002148_abnormal_hypersensitivity_rea | 1.19973106 |
| 76 | MP0005671_abnormal_response_to | 1.19196562 |
| 77 | MP0001984_abnormal_olfaction | 1.18705458 |
| 78 | MP0003448_altered_tumor_morphology | 1.15756428 |
| 79 | MP0008872_abnormal_physiological_respon | 1.13273491 |
| 80 | MP0005025_abnormal_response_to | 1.13036295 |
| 81 | MP0005164_abnormal_response_to | 1.12699504 |
| 82 | MP0000689_abnormal_spleen_morphology | 1.12689302 |
| 83 | MP0005000_abnormal_immune_tolerance | 1.12331255 |
| 84 | MP0001851_eye_inflammation | 1.12033794 |
| 85 | MP0004858_abnormal_nervous_system | 1.11586023 |
| 86 | MP0002429_abnormal_blood_cell | 1.10642292 |
| 87 | MP0003631_nervous_system_phenotype | 1.08074604 |
| 88 | MP0000249_abnormal_blood_vessel | 1.06086317 |
| 89 | MP0002722_abnormal_immune_system | 1.04654151 |
| 90 | MP0004142_abnormal_muscle_tone | 1.04087418 |
| 91 | MP0008260_abnormal_autophagy | 1.02643627 |
| 92 | MP0002184_abnormal_innervation | 1.01902896 |
| 93 | MP0003724_increased_susceptibility_to | 1.01380135 |
| 94 | MP0002066_abnormal_motor_capabilities/c | 1.01279147 |
| 95 | MP0005166_decreased_susceptibility_to | 1.00906566 |
| 96 | MP0009763_increased_sensitivity_to | 1.00283942 |
| 97 | MP0004883_abnormal_blood_vessel | 0.99541178 |
| 98 | MP0002877_abnormal_melanocyte_morpholog | 0.99414732 |
| 99 | MP0008057_abnormal_DNA_replication | 0.99024700 |
| 100 | MP0004484_altered_response_of | 0.98027095 |
| 101 | MP0001819_abnormal_immune_cell | 0.97869235 |
| 102 | MP0002420_abnormal_adaptive_immunity | 0.97180099 |
| 103 | MP0003091_abnormal_cell_migration | 0.96475486 |
| 104 | MP0009780_abnormal_chondrocyte_physiolo | 0.96249905 |
| 105 | MP0003763_abnormal_thymus_physiology | 0.95393787 |
| 106 | MP0000858_altered_metastatic_potential | 0.95343639 |
| 107 | MP0002095_abnormal_skin_pigmentation | 0.95299597 |
| 108 | MP0002452_abnormal_antigen_presenting | 0.94943509 |
| 109 | MP0002396_abnormal_hematopoietic_system | 0.94568546 |
| 110 | MP0002723_abnormal_immune_serum | 0.94330657 |
| 111 | MP0005310_abnormal_salivary_gland | 0.91456717 |
| 112 | MP0005058_abnormal_lysosome_morphology | 0.91099880 |
| 113 | MP0005535_abnormal_body_temperature | 0.90698285 |
| 114 | MP0002138_abnormal_hepatobiliary_system | 0.88645337 |
| 115 | MP0003045_fibrosis | 0.87679072 |
| 116 | MP0005397_hematopoietic_system_phenotyp | 0.87122902 |
| 117 | MP0001545_abnormal_hematopoietic_system | 0.87122902 |
| 118 | MP0009765_abnormal_xenobiotic_induced | 0.86123058 |
| 119 | MP0005165_increased_susceptibility_to | 0.85564225 |
| 120 | MP0001800_abnormal_humoral_immune | 0.85461345 |
| 121 | MP0003866_abnormal_defecation | 0.84351939 |
| 122 | MP0003787_abnormal_imprinting | 0.82957741 |
| 123 | MP0000955_abnormal_spinal_cord | 0.82445731 |
| 124 | MP0003690_abnormal_glial_cell | 0.82386752 |
| 125 | MP0002166_altered_tumor_susceptibility | 0.81294204 |
| 126 | MP0006276_abnormal_autonomic_nervous | 0.80305978 |
| 127 | MP0003329_amyloid_beta_deposits | 0.79871137 |
| 128 | MP0004808_abnormal_hematopoietic_stem | 0.78210402 |
| 129 | MP0005387_immune_system_phenotype | 0.78171576 |
| 130 | MP0001790_abnormal_immune_system | 0.78171576 |
| 131 | MP0001502_abnormal_circadian_rhythm | 0.77309978 |
| 132 | MP0004885_abnormal_endolymph | 0.76448884 |
| 133 | MP0003806_abnormal_nucleotide_metabolis | 0.75547703 |
| 134 | MP0002882_abnormal_neuron_morphology | 0.75523003 |
| 135 | MP0000604_amyloidosis | 0.72676055 |
| 136 | MP0002006_tumorigenesis | 0.72557134 |
| 137 | MP0000685_abnormal_immune_system | 0.72028295 |
| 138 | MP0002398_abnormal_bone_marrow | 0.71990288 |
| 139 | MP0003950_abnormal_plasma_membrane | 0.71804570 |
| 140 | MP0000920_abnormal_myelination | 0.69472734 |
| 141 | MP0002876_abnormal_thyroid_physiology | 0.69031707 |
| 142 | MP0009840_abnormal_foam_cell | 0.67629610 |
| 143 | MP0004130_abnormal_muscle_cell | 0.66938686 |
| 144 | MP0001663_abnormal_digestive_system | 0.66280253 |
| 145 | MP0009333_abnormal_splenocyte_physiolog | 0.66237087 |
| 146 | MP0005595_abnormal_vascular_smooth | 0.65316534 |
| 147 | MP0000716_abnormal_immune_system | 0.65022116 |
| 148 | MP0005084_abnormal_gallbladder_morpholo | 0.64522035 |
| 149 | MP0000778_abnormal_nervous_system | 0.64072175 |
| 150 | MP0002090_abnormal_vision | 0.64014645 |
| 151 | MP0001177_atelectasis | 0.61779478 |
| 152 | MP0002229_neurodegeneration | 0.61684049 |
| 153 | MP0000230_abnormal_systemic_arterial | 0.61044796 |
| 154 | MP0003453_abnormal_keratinocyte_physiol | 0.59653413 |
| 155 | MP0005647_abnormal_sex_gland | 0.57870230 |
| 156 | MP0000703_abnormal_thymus_morphology | 0.57689742 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.90603849 |
| 2 | Myokymia (HP:0002411) | 6.15206762 |
| 3 | Visual hallucinations (HP:0002367) | 4.72259223 |
| 4 | Focal seizures (HP:0007359) | 4.64092817 |
| 5 | Papilledema (HP:0001085) | 4.51966103 |
| 6 | Recurrent abscess formation (HP:0002722) | 4.25320688 |
| 7 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.24440437 |
| 8 | Febrile seizures (HP:0002373) | 4.03215993 |
| 9 | Recurrent bacterial skin infections (HP:0005406) | 3.95880798 |
| 10 | Spontaneous hematomas (HP:0007420) | 3.66986513 |
| 11 | Epileptic encephalopathy (HP:0200134) | 3.55934285 |
| 12 | Poor eye contact (HP:0000817) | 3.50512319 |
| 13 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 3.46797584 |
| 14 | Annular pancreas (HP:0001734) | 3.45245632 |
| 15 | Action tremor (HP:0002345) | 3.41072500 |
| 16 | Gaze-evoked nystagmus (HP:0000640) | 3.39877460 |
| 17 | Autoimmune thrombocytopenia (HP:0001973) | 3.33572134 |
| 18 | Progressive cerebellar ataxia (HP:0002073) | 3.30983183 |
| 19 | Broad-based gait (HP:0002136) | 3.26643748 |
| 20 | Progressive inability to walk (HP:0002505) | 3.18900587 |
| 21 | Atonic seizures (HP:0010819) | 3.18816866 |
| 22 | Increased cerebral lipofuscin (HP:0011813) | 3.17198623 |
| 23 | Eczematoid dermatitis (HP:0000976) | 3.12413777 |
| 24 | Generalized tonic-clonic seizures (HP:0002069) | 3.07430425 |
| 25 | Conjunctival telangiectasia (HP:0000524) | 3.05419938 |
| 26 | Gingival bleeding (HP:0000225) | 3.04310117 |
| 27 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.03491073 |
| 28 | Keratoconjunctivitis sicca (HP:0001097) | 3.02747710 |
| 29 | Absence seizures (HP:0002121) | 3.02230702 |
| 30 | Abnormal social behavior (HP:0012433) | 2.92559684 |
| 31 | Impaired social interactions (HP:0000735) | 2.92559684 |
| 32 | Menorrhagia (HP:0000132) | 2.90860813 |
| 33 | Mutism (HP:0002300) | 2.90267128 |
| 34 | Abnormal platelet volume (HP:0011876) | 2.87999500 |
| 35 | Supranuclear gaze palsy (HP:0000605) | 2.87524219 |
| 36 | Stereotypic behavior (HP:0000733) | 2.85930771 |
| 37 | Disinhibition (HP:0000734) | 2.85567805 |
| 38 | Dysostosis multiplex (HP:0000943) | 2.85057872 |
| 39 | Dialeptic seizures (HP:0011146) | 2.84400683 |
| 40 | Myositis (HP:0100614) | 2.83487833 |
| 41 | Postural instability (HP:0002172) | 2.82241802 |
| 42 | Arterial thrombosis (HP:0004420) | 2.81696860 |
| 43 | Hematochezia (HP:0002573) | 2.80887950 |
| 44 | Hemoptysis (HP:0002105) | 2.79460394 |
| 45 | Autoimmune hemolytic anemia (HP:0001890) | 2.79139112 |
| 46 | Increased mean platelet volume (HP:0011877) | 2.78762776 |
| 47 | Keratoconjunctivitis (HP:0001096) | 2.76866127 |
| 48 | Mediastinal lymphadenopathy (HP:0100721) | 2.76853787 |
| 49 | Recurrent viral infections (HP:0004429) | 2.76392499 |
| 50 | Impaired smooth pursuit (HP:0007772) | 2.73966345 |
| 51 | Pulmonary infiltrates (HP:0002113) | 2.72115676 |
| 52 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.71748099 |
| 53 | Recurrent cutaneous fungal infections (HP:0011370) | 2.71260968 |
| 54 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.71260968 |
| 55 | Purpura (HP:0000979) | 2.70911062 |
| 56 | Diplopia (HP:0000651) | 2.69586602 |
| 57 | Abnormality of binocular vision (HP:0011514) | 2.69586602 |
| 58 | T lymphocytopenia (HP:0005403) | 2.68872049 |
| 59 | Vasculitis (HP:0002633) | 2.66380688 |
| 60 | Amyloidosis (HP:0011034) | 2.66233226 |
| 61 | Encephalitis (HP:0002383) | 2.65465002 |
| 62 | Abnormality of T cell number (HP:0011839) | 2.65132862 |
| 63 | Depression (HP:0000716) | 2.63681901 |
| 64 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.63164885 |
| 65 | Anxiety (HP:0000739) | 2.59807638 |
| 66 | Chest pain (HP:0100749) | 2.59163791 |
| 67 | Prolonged bleeding time (HP:0003010) | 2.58216066 |
| 68 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.57201513 |
| 69 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.54843321 |
| 70 | Loss of speech (HP:0002371) | 2.51038293 |
| 71 | Inappropriate behavior (HP:0000719) | 2.50508722 |
| 72 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.47140094 |
| 73 | Scanning speech (HP:0002168) | 2.45567176 |
| 74 | Truncal ataxia (HP:0002078) | 2.43623930 |
| 75 | Obstructive lung disease (HP:0006536) | 2.42706949 |
| 76 | Chronic obstructive pulmonary disease (HP:0006510) | 2.42706949 |
| 77 | Hyperventilation (HP:0002883) | 2.42691762 |
| 78 | Vertigo (HP:0002321) | 2.39728085 |
| 79 | Abnormal platelet function (HP:0011869) | 2.39574773 |
| 80 | Impaired platelet aggregation (HP:0003540) | 2.39574773 |
| 81 | Bradykinesia (HP:0002067) | 2.38945689 |
| 82 | Vacuolated lymphocytes (HP:0001922) | 2.37669751 |
| 83 | Torticollis (HP:0000473) | 2.37494827 |
| 84 | Spinal canal stenosis (HP:0003416) | 2.34188476 |
| 85 | Gastrointestinal infarctions (HP:0005244) | 2.34070781 |
| 86 | Urticaria (HP:0001025) | 2.31314942 |
| 87 | Resting tremor (HP:0002322) | 2.31258566 |
| 88 | Gangrene (HP:0100758) | 2.30214489 |
| 89 | Thrombocytosis (HP:0001894) | 2.29397169 |
| 90 | Inability to walk (HP:0002540) | 2.29036978 |
| 91 | Pulmonary embolism (HP:0002204) | 2.28618353 |
| 92 | Recurrent skin infections (HP:0001581) | 2.28346215 |
| 93 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.27609965 |
| 94 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.27271607 |
| 95 | Generalized hypopigmentation of hair (HP:0011358) | 2.27198728 |
| 96 | Abnormal eating behavior (HP:0100738) | 2.26823927 |
| 97 | Cellulitis (HP:0100658) | 2.25755595 |
| 98 | Abnormality of macrophages (HP:0004311) | 2.25329090 |
| 99 | Dysdiadochokinesis (HP:0002075) | 2.25179608 |
| 100 | Thick nail (HP:0001805) | 2.24000592 |
| 101 | Myocardial infarction (HP:0001658) | 2.23229645 |
| 102 | Focal dystonia (HP:0004373) | 2.22231724 |
| 103 | Colitis (HP:0002583) | 2.20859869 |
| 104 | Ocular albinism (HP:0001107) | 2.20560905 |
| 105 | Amaurosis fugax (HP:0100576) | 2.19526103 |
| 106 | Agnosia (HP:0010524) | 2.17843088 |
| 107 | Dysmetria (HP:0001310) | 2.17054570 |
| 108 | Abnormality of B cell number (HP:0010975) | 2.16171638 |
| 109 | Leukocytosis (HP:0001974) | 2.15402919 |
| 110 | Abnormality of the periventricular white matter (HP:0002518) | 2.14154300 |
| 111 | Optic neuritis (HP:0100653) | 2.13098375 |
| 112 | Retrobulbar optic neuritis (HP:0100654) | 2.13098375 |
| 113 | Iris hypopigmentation (HP:0007730) | 2.11335542 |
| 114 | Polycythemia (HP:0001901) | 2.08728752 |
| 115 | Ankle clonus (HP:0011448) | 2.06993840 |
| 116 | Inflammation of the large intestine (HP:0002037) | 2.06813483 |
| 117 | Dysmetric saccades (HP:0000641) | 2.06118409 |
| 118 | Recurrent fungal infections (HP:0002841) | 2.05582391 |
| 119 | Mucosal telangiectasiae (HP:0100579) | 2.05471966 |
| 120 | Episodic fever (HP:0001954) | 2.04276166 |
| 121 | Craniofacial dystonia (HP:0012179) | 2.04061131 |
| 122 | Abnormality of the pleura (HP:0002103) | 2.04059514 |
| 123 | Acute lymphatic leukemia (HP:0006721) | 2.03510662 |
| 124 | Orchitis (HP:0100796) | 2.03185445 |
| 125 | Fair hair (HP:0002286) | 2.02888918 |
| 126 | Stomatitis (HP:0010280) | 2.02578665 |
| 127 | Intention tremor (HP:0002080) | 2.01519113 |
| 128 | Apathy (HP:0000741) | 2.01198261 |
| 129 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.00950847 |
| 130 | Genetic anticipation (HP:0003743) | 2.00597790 |
| 131 | Petechiae (HP:0000967) | 2.00149805 |
| 132 | Limb dystonia (HP:0002451) | 1.99637707 |
| 133 | Periodontitis (HP:0000704) | 1.98473318 |
| 134 | Cerebral hemorrhage (HP:0001342) | 1.98355847 |
| 135 | Memory impairment (HP:0002354) | 1.98312446 |
| 136 | Diminished motivation (HP:0000745) | 1.98097847 |
| 137 | Viral hepatitis (HP:0006562) | 1.96979883 |
| 138 | Abnormality of the prostate (HP:0008775) | 1.96732682 |
| 139 | Basal ganglia calcification (HP:0002135) | 1.95739521 |
| 140 | Abnormality of T cells (HP:0002843) | 1.95410174 |
| 141 | Hepatosplenomegaly (HP:0001433) | 1.95176163 |
| 142 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.94935044 |
| 143 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.94935044 |
| 144 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.94935044 |
| 145 | Protruding tongue (HP:0010808) | 1.94604815 |
| 146 | Epistaxis (HP:0000421) | 1.94412017 |
| 147 | Hemiplegia (HP:0002301) | 1.93752288 |
| 148 | J-shaped sella turcica (HP:0002680) | 1.93470041 |
| 149 | Lower limb amyotrophy (HP:0007210) | 1.92999274 |
| 150 | Nonprogressive disorder (HP:0003680) | 1.92782314 |
| 151 | Abnormality of saccadic eye movements (HP:0000570) | 1.91554513 |
| 152 | Fatigue (HP:0012378) | 1.90827139 |
| 153 | Polyneuropathy (HP:0001271) | 1.90533886 |
| 154 | Absent frontal sinuses (HP:0002688) | 1.90211838 |
| 155 | Pointed chin (HP:0000307) | 1.89853423 |
| 156 | Alveolar cell carcinoma (HP:0006519) | 1.89672128 |
| 157 | Neurodegeneration (HP:0002180) | 1.89458634 |
| 158 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.89122100 |
| 159 | Hypothermia (HP:0002045) | 1.89072502 |
| 160 | Ankyloglossia (HP:0010296) | 1.87170661 |
| 161 | Neuronal loss in central nervous system (HP:0002529) | 1.86453977 |
| 162 | Gingivitis (HP:0000230) | 1.86283103 |
| 163 | Palpebral edema (HP:0100540) | 1.83785349 |
| 164 | Meningitis (HP:0001287) | 1.82955213 |
| 165 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.81158774 |
| 166 | Abnormality of glycolipid metabolism (HP:0010969) | 1.81158774 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.82602296 |
| 2 | EPHA4 | 4.46686802 |
| 3 | NTRK3 | 3.92969287 |
| 4 | MAP3K9 | 3.19373417 |
| 5 | MAP3K12 | 3.00514529 |
| 6 | FES | 2.70707995 |
| 7 | TAOK3 | 2.62041084 |
| 8 | TNIK | 2.61039937 |
| 9 | CAMKK2 | 2.52375610 |
| 10 | MAP3K13 | 2.48454167 |
| 11 | TIE1 | 2.47876220 |
| 12 | MAP2K7 | 2.35474738 |
| 13 | DAPK2 | 2.28529460 |
| 14 | IRAK3 | 2.27828077 |
| 15 | CAMKK1 | 2.19995337 |
| 16 | MAP2K3 | 2.08590543 |
| 17 | CSK | 2.08385127 |
| 18 | PDK2 | 2.07605078 |
| 19 | ACVR1B | 2.06115303 |
| 20 | MINK1 | 2.02422231 |
| 21 | KSR2 | 2.01918837 |
| 22 | DAPK1 | 1.97772136 |
| 23 | TGFBR2 | 1.91967097 |
| 24 | KIT | 1.85959576 |
| 25 | ARAF | 1.85637919 |
| 26 | MAP3K4 | 1.85163532 |
| 27 | FRK | 1.83994268 |
| 28 | TYK2 | 1.68844339 |
| 29 | MATK | 1.60664723 |
| 30 | INSRR | 1.49617806 |
| 31 | IKBKB | 1.47535565 |
| 32 | BMPR2 | 1.44398973 |
| 33 | JAK3 | 1.43737398 |
| 34 | PIK3CG | 1.42896056 |
| 35 | NTRK2 | 1.39631152 |
| 36 | IRAK2 | 1.37864906 |
| 37 | IRAK1 | 1.31527286 |
| 38 | IRAK4 | 1.30983724 |
| 39 | MAP2K4 | 1.28604580 |
| 40 | CDK19 | 1.28208216 |
| 41 | ITK | 1.28147677 |
| 42 | RAF1 | 1.27340864 |
| 43 | MAP3K3 | 1.26957027 |
| 44 | SIK2 | 1.25982398 |
| 45 | TRPM7 | 1.25097919 |
| 46 | NTRK1 | 1.24234667 |
| 47 | BLK | 1.23879961 |
| 48 | MARK1 | 1.22406272 |
| 49 | SYK | 1.16493993 |
| 50 | CDK5 | 1.10821311 |
| 51 | MAP3K6 | 1.07184750 |
| 52 | KSR1 | 1.05229175 |
| 53 | GRK5 | 1.04287181 |
| 54 | TNK2 | 1.02634356 |
| 55 | SGK2 | 0.97960769 |
| 56 | CAMK1 | 0.97644325 |
| 57 | PRPF4B | 0.96262001 |
| 58 | LCK | 0.95371775 |
| 59 | MAPKAPK5 | 0.94899230 |
| 60 | PDK1 | 0.94602201 |
| 61 | GRK6 | 0.94324834 |
| 62 | PLK2 | 0.93760052 |
| 63 | CASK | 0.92951661 |
| 64 | MUSK | 0.92316156 |
| 65 | TAOK2 | 0.90500409 |
| 66 | PAK6 | 0.89927931 |
| 67 | OXSR1 | 0.88545842 |
| 68 | TAOK1 | 0.88123563 |
| 69 | MAP4K1 | 0.84452861 |
| 70 | MAP3K14 | 0.83247144 |
| 71 | MAP3K1 | 0.81143311 |
| 72 | MAP3K11 | 0.80055572 |
| 73 | BMPR1B | 0.80022080 |
| 74 | SIK3 | 0.79955568 |
| 75 | MAPK13 | 0.79496784 |
| 76 | MAP3K5 | 0.77682285 |
| 77 | IKBKE | 0.77022646 |
| 78 | ADRBK2 | 0.76169924 |
| 79 | MAPK12 | 0.75148158 |
| 80 | TEC | 0.74824221 |
| 81 | TGFBR1 | 0.73203829 |
| 82 | HCK | 0.72638514 |
| 83 | SGK3 | 0.71692385 |
| 84 | YES1 | 0.69968009 |
| 85 | PIM1 | 0.69516444 |
| 86 | MAP3K2 | 0.69410699 |
| 87 | TXK | 0.68032887 |
| 88 | FLT3 | 0.67791051 |
| 89 | BTK | 0.67273912 |
| 90 | PTK2B | 0.67091222 |
| 91 | MARK3 | 0.66909231 |
| 92 | FER | 0.66147079 |
| 93 | RET | 0.64454344 |
| 94 | FGR | 0.64261999 |
| 95 | PRKCH | 0.63820444 |
| 96 | PRKCG | 0.63713294 |
| 97 | SGK1 | 0.63033527 |
| 98 | PDPK1 | 0.62326589 |
| 99 | MAPK7 | 0.61374673 |
| 100 | CLK1 | 0.60992201 |
| 101 | CAMK2A | 0.60563098 |
| 102 | LYN | 0.58131158 |
| 103 | JAK1 | 0.56340437 |
| 104 | SGK223 | 0.56007154 |
| 105 | SGK494 | 0.56007154 |
| 106 | WNK1 | 0.55614306 |
| 107 | CCNB1 | 0.55411399 |
| 108 | GRK7 | 0.53828692 |
| 109 | FYN | 0.53637956 |
| 110 | CDK8 | 0.52571479 |
| 111 | PINK1 | 0.52536753 |
| 112 | ERBB3 | 0.52445151 |
| 113 | RPS6KA2 | 0.51861665 |
| 114 | RIPK1 | 0.51292699 |
| 115 | TBK1 | 0.51031572 |
| 116 | ABL1 | 0.50381003 |
| 117 | MOS | 0.50276829 |
| 118 | CAMK4 | 0.49463817 |
| 119 | STK11 | 0.48889465 |
| 120 | MAP2K6 | 0.47901532 |
| 121 | CDK18 | 0.45449870 |
| 122 | EIF2AK3 | 0.44145563 |
| 123 | SCYL2 | 0.42828698 |
| 124 | BMX | 0.42778760 |
| 125 | NEK6 | 0.42141454 |
| 126 | CDK6 | 0.41717587 |
| 127 | NEK9 | 0.40166816 |
| 128 | CDK15 | 0.39907052 |
| 129 | ALK | 0.39781025 |
| 130 | CSF1R | 0.39725453 |
| 131 | ZAP70 | 0.39687759 |
| 132 | BRSK1 | 0.39583280 |
| 133 | DDR2 | 0.38901237 |
| 134 | JAK2 | 0.38785689 |
| 135 | PDGFRB | 0.38662532 |
| 136 | EGFR | 0.38656968 |
| 137 | CAMK2B | 0.37856288 |
| 138 | CHUK | 0.37569909 |
| 139 | IGF1R | 0.35696446 |
| 140 | PRKD3 | 0.35571035 |
| 141 | PKN1 | 0.35210826 |
| 142 | CDK11A | 0.34840842 |
| 143 | STK38 | 0.34360326 |
| 144 | PRKCD | 0.33797676 |
| 145 | MAPK4 | 0.32078321 |
| 146 | CAMK1G | 0.31794020 |
| 147 | CDK14 | 0.31012455 |
| 148 | ABL2 | 0.24812028 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Olfactory transduction_Homo sapiens_hsa04740 | 3.02826201 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 2.94523726 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 2.73352412 |
| 4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.66656779 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.62413144 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.56682180 |
| 7 | Morphine addiction_Homo sapiens_hsa05032 | 2.52591267 |
| 8 | Circadian entrainment_Homo sapiens_hsa04713 | 2.45345563 |
| 9 | Long-term potentiation_Homo sapiens_hsa04720 | 2.42886481 |
| 10 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.36680971 |
| 11 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.32602621 |
| 12 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.30289373 |
| 13 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.21261679 |
| 14 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.20463004 |
| 15 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.19472338 |
| 16 | GABAergic synapse_Homo sapiens_hsa04727 | 2.14671196 |
| 17 | Malaria_Homo sapiens_hsa05144 | 2.09930084 |
| 18 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.92085760 |
| 19 | Salivary secretion_Homo sapiens_hsa04970 | 1.91560473 |
| 20 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.85678010 |
| 21 | Cocaine addiction_Homo sapiens_hsa05030 | 1.72186469 |
| 22 | Legionellosis_Homo sapiens_hsa05134 | 1.72011230 |
| 23 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.68261579 |
| 24 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.66568335 |
| 25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.65305769 |
| 26 | Renin secretion_Homo sapiens_hsa04924 | 1.64560237 |
| 27 | Taste transduction_Homo sapiens_hsa04742 | 1.61239166 |
| 28 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.60791831 |
| 29 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.58950220 |
| 30 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.53183667 |
| 31 | Long-term depression_Homo sapiens_hsa04730 | 1.51851249 |
| 32 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.46490395 |
| 33 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.45934331 |
| 34 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.44555429 |
| 35 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.37777882 |
| 36 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.37007446 |
| 37 | Viral myocarditis_Homo sapiens_hsa05416 | 1.34803770 |
| 38 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.34468228 |
| 39 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.31834815 |
| 40 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.30893207 |
| 41 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.29771082 |
| 42 | Other glycan degradation_Homo sapiens_hsa00511 | 1.29494603 |
| 43 | Insulin secretion_Homo sapiens_hsa04911 | 1.26871173 |
| 44 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.22979922 |
| 45 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.21407012 |
| 46 | Leishmaniasis_Homo sapiens_hsa05140 | 1.20793957 |
| 47 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.15391368 |
| 48 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.13522482 |
| 49 | Measles_Homo sapiens_hsa05162 | 1.12320067 |
| 50 | Gap junction_Homo sapiens_hsa04540 | 1.11767072 |
| 51 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.10713713 |
| 52 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.10518979 |
| 53 | Platelet activation_Homo sapiens_hsa04611 | 1.10280926 |
| 54 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.10123755 |
| 55 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.08905390 |
| 56 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.08049227 |
| 57 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.06965502 |
| 58 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.05785756 |
| 59 | Glioma_Homo sapiens_hsa05214 | 1.05013348 |
| 60 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.04650044 |
| 61 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.04308958 |
| 62 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.02270115 |
| 63 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.01548432 |
| 64 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.01069566 |
| 65 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.99372962 |
| 66 | Tuberculosis_Homo sapiens_hsa05152 | 0.97837921 |
| 67 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.93010054 |
| 68 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.92898079 |
| 69 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.92261682 |
| 70 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.91150591 |
| 71 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.90062833 |
| 72 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.88610854 |
| 73 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.87617725 |
| 74 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.87200456 |
| 75 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.86983303 |
| 76 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.85075831 |
| 77 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.84054062 |
| 78 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.83748525 |
| 79 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.80896048 |
| 80 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.79836934 |
| 81 | Asthma_Homo sapiens_hsa05310 | 0.79781957 |
| 82 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.77337693 |
| 83 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.76786153 |
| 84 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.76094714 |
| 85 | Pertussis_Homo sapiens_hsa05133 | 0.76063493 |
| 86 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.76011341 |
| 87 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.75642129 |
| 88 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.75621212 |
| 89 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.75089272 |
| 90 | Salmonella infection_Homo sapiens_hsa05132 | 0.74804239 |
| 91 | Amoebiasis_Homo sapiens_hsa05146 | 0.74152392 |
| 92 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.73822135 |
| 93 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.73322446 |
| 94 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.73134290 |
| 95 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.72018084 |
| 96 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.70104592 |
| 97 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.68480682 |
| 98 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.68308306 |
| 99 | Apoptosis_Homo sapiens_hsa04210 | 0.68034417 |
| 100 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.67721405 |
| 101 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.67527461 |
| 102 | Phagosome_Homo sapiens_hsa04145 | 0.67299312 |
| 103 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.67122377 |
| 104 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.65185841 |
| 105 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.65135377 |
| 106 | Hepatitis C_Homo sapiens_hsa05160 | 0.64848862 |
| 107 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.64337470 |
| 108 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.62381141 |
| 109 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.62321273 |
| 110 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.60433626 |
| 111 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.59259127 |
| 112 | Melanogenesis_Homo sapiens_hsa04916 | 0.58458019 |
| 113 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.57481302 |
| 114 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.55977126 |
| 115 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.54705925 |
| 116 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.54407831 |
| 117 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.53347795 |
| 118 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.52908800 |
| 119 | Lysosome_Homo sapiens_hsa04142 | 0.52463439 |
| 120 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.51585434 |
| 121 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.51202549 |
| 122 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.49991517 |
| 123 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.49288161 |
| 124 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.47022528 |
| 125 | Shigellosis_Homo sapiens_hsa05131 | 0.46153741 |
| 126 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.45582646 |
| 127 | Influenza A_Homo sapiens_hsa05164 | 0.44693401 |
| 128 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.44500001 |
| 129 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.43464952 |
| 130 | Endocytosis_Homo sapiens_hsa04144 | 0.42848694 |
| 131 | Alcoholism_Homo sapiens_hsa05034 | 0.41307938 |
| 132 | Bladder cancer_Homo sapiens_hsa05219 | 0.39673938 |
| 133 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.39556366 |
| 134 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.38788717 |
| 135 | Hepatitis B_Homo sapiens_hsa05161 | 0.38183824 |
| 136 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.35978600 |
| 137 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.35428759 |
| 138 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.34748350 |
| 139 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.34009967 |
| 140 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.30692621 |
| 141 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.30118096 |
| 142 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.29955165 |

